FUJIAN HAIXI PHARMACEUTICALS CO., LTD. - H SHARES
(HKEX: 2637)
Fujian Haixi New Drug Creation Co., Ltd. engages in the research and development, manufacture, and sale of pharmaceutical products. It offers generic drugs for digestive, cardiovascular, endocrine, nervous, and inflammation therapeutic areas. The company was founded by Xin Shan Kang and Yan Feng on March 27, 2012 and is headquartered in Fuzhou, China.
141.400 -
-1.400
(-0.98%)
Range
139.800 - 145.500
(4.08%)
Open
142.900
Previous Close
142.800
Bid Price
141.300
Bid Volume
('000)
0.1
Ask Price
141.500
Ask Volume
('000)
1.5
Volume
('000)
41.2
Value
5,892,169
Remark
-
Delayed prices. Updated at 29 Jan 2026 14:58.
Data powered by
View All Events
Loading Chart...
Please login to view stock data and analysis
